Therapy News and Research

RSS

New approach could overcome large immunosuppressive tumors

Harnessing the body's own immune system to destroy tumors is a tantalizing prospect that has yet to realize its full potential. However, a new advance from MIT may bring this strategy, known as cancer immunotherapy, closer to becoming reality.

24 Oct 2016

Identification of new lung cancer subtypes could lead to personalized immunotherapies

Personalized therapies can potentially improve the outcomes of patients with lung cancer, but how to best design such an approach is not always clear.

24 Oct 2016

Scientists identify genetic cause and biological mechanisms linked to new human immunodeficiency

A multi-institutional, international team of scientists has discovered the genetic cause and biological mechanisms linked to a new human immunodeficiency. The study, which is published in Nature Immunology, also identifies a potential treatment.

24 Oct 2016

New scaffold could improve outcome of periodontal regenerative surgery

A new regenerative scaffold made of biosafe collagen hydrogel and collagensponge could possess the ability of retaining fibroblastic growth factor-2 (FGF2) and stimulate the periodontal tissue regeneration, according to new research published in The Open Dentistry Journal.

24 Oct 2016

Basal tumor cell marker could help physicians personalize care for patients with bladder cancer

Tumor cells collected during the removal of a cancerous bladder and - in some cases - transplanted into mice with weakened immune systems, could help physicians rapidly identify high-risk cancers, determine prognosis and refine the use of biomarkers to personalize care for patients with this common cancer, according to a study published online on Oct. 24, 2016, in Scientific Reports.

24 Oct 2016

Fission yeast could help discover novel cancer drugs

Cancer is a notoriously difficult disease to treat. Not only do a wide variety of cancers exist, requiring specialized treatments for each type, but cancer cells within an individual can morph and render previously potent therapeutics ineffective.

24 Oct 2016

Novel ‘gene therapy in a box’ could effectively deliver modified blood stem cells

A table-top device that enables medical staff to genetically manipulate a patient's blood to deliver potential new therapies for cancer, HIV and other diseases would eliminate the need for multi-million-dollar "clean rooms," making gene therapy more possible for even the poorest of countries.

24 Oct 2016

Swiss specialists report success of new cell-based repair technology for articular cartilage defects

Writing in The Lancet, Swiss doctors report that cartilage cells harvested from patients’ own noses have been used to successfully produce cartilage transplants for the treatment of the knees of 10 adults (aged 18-55 years) whose cartilage was damaged by injury.

24 Oct 2016

TxCell collaborates with UBC to develop CAR-Treg therapy to prevent graft rejection in organ transplantation

TxCell SA, a biotechnology company developing innovative, personalized cellular immunotherapies using regulatory T cells (Treg) to treat severe chronic inflammatory and autoimmune diseases, today announces the signature of a strategic R&D collaboration agreement with the University of British Columbia (UBC) in Vancouver, Canada, a leading global center for multidisciplinary research and teaching.

24 Oct 2016

ERAS programs help patients better prepare for surgery and recover faster, studies reveal

Enhanced recovery after surgery (ERAS) programs, an important component of the Perioperative Surgical Home (PSH), are helping patients better prepare for surgery and recuperate faster afterward, according to two new studies being presented at the ANESTHESIOLOGY 2016 annual meeting.

24 Oct 2016

Scientists discover new option for treating malignant pleural mesothelioma

Researchers at the Comprehensive Cancer Center of MedUni Vienna and Vienna General Hospital have discovered a new option for treating malignant pleural mesothelioma.

24 Oct 2016

Many back pain patients taking opioids get limited relief and worry about side effects, study finds

Millions of people take opioids for chronic back pain, but many of them get limited relief while experiencing side effects and worrying about the stigma associated with taking them, suggests research presented at the ANESTHESIOLOGY 2016 annual meeting.

24 Oct 2016

Novel lipid-based therapeutic shows promise for combating drug resistance in AML

Researchers at the Medical University of South Carolina Hollings Cancer Center have discovered a mechanism that confers resistance to drugs used to treat certain types of acute myeloid leukemia (AML).

24 Oct 2016

Sanford opens new immunotherapy study on colorectal cancer

Sanford Health has opened another clinical trial exploring the power of the body's immune system to fight cancer.

21 Oct 2016

URI researchers design smart gloves to measure tremors and rigidity in Parkinson's patients

Prescribing a medication plan for a patient with Parkinson's disease is a big challenge for doctors, but now a University of Rhode Island biomedical engineering professor and his students are making great strides in solving that problem with their groundbreaking research.

21 Oct 2016

Robot-assisted surgery at NYU Lutheran offers hope to women with endometrial cancer

Nandi Kumar Carpen, a 51-year-old wife, mother of two young girls, and a nurse at a major city hospital, noticed some "spotty" bleeding outside of her regular menstrual cycle.

21 Oct 2016

Study assesses impact of diabetes mellitus on cardiac geometry

A study of U.S. Hispanics with diabetes mellitus showed a link between impaired glucose regulation and adverse measures of cardiac function and structure.

21 Oct 2016

New research examines use of nanotechnology to improve delivery of drugs to HIV patients

New research led by the University of Liverpool aims to improve the administration and availability of drug therapies to HIV patients through the use of nanotechnology.

21 Oct 2016

Cedars-Sinai receives FDA approval to examine safety of combination stem cell-gene therapy in ALS patients

Cedars-Sinai regenerative medicine investigators have received approval from the U.S. Food and Drug Administration to test a combination stem cell-gene therapy they developed to stall the progression of amyotrophic lateral sclerosis, a neurological disease that causes progressive paralysis and ultimately death.

21 Oct 2016

Study shows how damage to RNA-binding protein contributes to ALS

Although only 10 percent of amyotrophic lateral sclerosis (ALS) cases are hereditary, a significant number of them are caused by mutations that affect proteins that bind RNA, a type of genetic material.

21 Oct 2016

Therapy News and Research

New approach could overcome large immunosuppressive tumors

Identification of new lung cancer subtypes could lead to personalized immunotherapies

Scientists identify genetic cause and biological mechanisms linked to new human immunodeficiency

New scaffold could improve outcome of periodontal regenerative surgery

Basal tumor cell marker could help physicians personalize care for patients with bladder cancer

Fission yeast could help discover novel cancer drugs

Novel ‘gene therapy in a box’ could effectively deliver modified blood stem cells

Swiss specialists report success of new cell-based repair technology for articular cartilage defects

TxCell collaborates with UBC to develop CAR-Treg therapy to prevent graft rejection in organ transplantation

ERAS programs help patients better prepare for surgery and recover faster, studies reveal

Scientists discover new option for treating malignant pleural mesothelioma

Many back pain patients taking opioids get limited relief and worry about side effects, study finds

Novel lipid-based therapeutic shows promise for combating drug resistance in AML

Sanford opens new immunotherapy study on colorectal cancer

URI researchers design smart gloves to measure tremors and rigidity in Parkinson's patients

Robot-assisted surgery at NYU Lutheran offers hope to women with endometrial cancer

Study assesses impact of diabetes mellitus on cardiac geometry

New research examines use of nanotechnology to improve delivery of drugs to HIV patients

Cedars-Sinai receives FDA approval to examine safety of combination stem cell-gene therapy in ALS patients

Study shows how damage to RNA-binding protein contributes to ALS

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News